Clinical trials
Completed Leukemia, Myelomonocytic, Chronic trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 2 |
| 2005 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 1 |
| 2020 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 4 |
| Fred Hutchinson Cancer Center | 3 |
| Astex Pharmaceuticals, Inc. | 2 |
| Heinrich-Heine University, Duesseldorf | 2 |
| Novartis Pharmaceuticals | 2 |
| Traws Pharma, Inc. | 2 |
| AstraZeneca | 1 |
| Millennium Pharmaceuticals, Inc. | 1 |
| Pfizer | 1 |
| Prelude Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelomonocytic, Chronic | 22 |
| Leukemia, Myeloid, Acute | 17 |
| Myelodysplastic Syndromes | 15 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 8 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 7 |
| Hodgkin Disease | 6 |
| Lymphoma, B-Cell, Marginal Zone | 6 |
| Lymphoma, Large B-Cell, Diffuse | 6 |
| Lymphoma, Mantle-Cell | 6 |
| Lymphoma, Non-Hodgkin | 6 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.